Neuroscience
The Parkinson Disease event presented by the NIH, which I noted here earlier [BrainBlog post on 11 October 2005] was broadcast live today on C-SPAN: Advances in Parkinson's Disease.
Check the C-SPAN website for any reairing dates and times.
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Rasagiline And Parkinson's Disease
From the FDA on the 17th of May: FDA Approves New Treatment for Parkinson's Disease The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease. The drug is a monoamine...
- Upcoming Event: Washington, D.c., 20 October 2005
A press release from the NIH: Tuesday, October 11, 2005 CONTACT: Margo Warren 301-496-5751 Science Reporters Briefing: New Advances in Parkinson’s Research and Treatment What: The National Institute of Neurological Disorders...
- Amgen's Gdnf And Parkinson Disease
From the AP, via The WashingtonPost.com website, concerning glial cell line-derived neurotrophic factor (GDNF): Autopsy Shows Parkinson's Drug's Progress By RANDOLPH E. SCHMID The Associated Press Friday, July 1, 2005; 3:57 PM WASHINGTON --...
- Parkinson Disease: Lrrk2, Park8, And Dardarin
From the BBC: Target found for Parkinson's test A gene mutation which could be behind one in 25 cases of Parkinson's disease has been discovered by scientists. It is hoped the findings could lead to the earlier detection of the disease...
- Dbs Patient To Appear On Woman’s Media Center Live
In recognition of Parkinson’s Awareness Month, Robin Morgan from Woman’s Media Center Live, will be interviewing Lori Katz, a patient of Gordon Baltuch, MD, Director of the Center for Functional and Restorative Neurosurgery. The interview will be...
Neuroscience
Parkinson Disease Update Live on C-SPAN Today
The Parkinson Disease event presented by the NIH, which I noted here earlier [BrainBlog post on 11 October 2005] was broadcast live today on C-SPAN: Advances in Parkinson's Disease.
Check the C-SPAN website for any reairing dates and times.
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Rasagiline And Parkinson's Disease
From the FDA on the 17th of May: FDA Approves New Treatment for Parkinson's Disease The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease. The drug is a monoamine...
- Upcoming Event: Washington, D.c., 20 October 2005
A press release from the NIH: Tuesday, October 11, 2005 CONTACT: Margo Warren 301-496-5751 Science Reporters Briefing: New Advances in Parkinson’s Research and Treatment What: The National Institute of Neurological Disorders...
- Amgen's Gdnf And Parkinson Disease
From the AP, via The WashingtonPost.com website, concerning glial cell line-derived neurotrophic factor (GDNF): Autopsy Shows Parkinson's Drug's Progress By RANDOLPH E. SCHMID The Associated Press Friday, July 1, 2005; 3:57 PM WASHINGTON --...
- Parkinson Disease: Lrrk2, Park8, And Dardarin
From the BBC: Target found for Parkinson's test A gene mutation which could be behind one in 25 cases of Parkinson's disease has been discovered by scientists. It is hoped the findings could lead to the earlier detection of the disease...
- Dbs Patient To Appear On Woman’s Media Center Live
In recognition of Parkinson’s Awareness Month, Robin Morgan from Woman’s Media Center Live, will be interviewing Lori Katz, a patient of Gordon Baltuch, MD, Director of the Center for Functional and Restorative Neurosurgery. The interview will be...